Rapid Micro Biosystems (RPID) to Post Quarterly Earnings on Friday

Rapid Micro Biosystems (NASDAQ:RPID) will likely be issuing its Q2 2026 results before the market opens on Friday, August 7th. Analysts expect Rapid Micro Biosystems to announce earnings of ($0.26) per share and revenue of $7.8750 million for the quarter. Parties are encouraged to explore the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Friday, August 7, 2026 at 8:30 AM ET.

Rapid Micro Biosystems (NASDAQ:RPID) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.31) earnings per share for the quarter, missing the consensus estimate of ($0.25) by ($0.06). Rapid Micro Biosystems had a negative return on equity of 131.52% and a negative net margin of 145.81%.The business had revenue of $8.00 million during the quarter, compared to analyst estimates of $7.60 million. On average, analysts expect Rapid Micro Biosystems to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Rapid Micro Biosystems Stock Performance

Shares of NASDAQ RPID opened at $2.06 on Wednesday. The company has a current ratio of 2.57, a quick ratio of 1.66 and a debt-to-equity ratio of 0.93. Rapid Micro Biosystems has a 12 month low of $1.66 and a 12 month high of $4.94. The company has a 50 day simple moving average of $1.90 and a two-hundred day simple moving average of $2.70. The stock has a market cap of $95.11 million, a price-to-earnings ratio of -1.84 and a beta of 1.44.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. American Century Companies Inc. grew its position in shares of Rapid Micro Biosystems by 46.1% during the 2nd quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock valued at $58,000 after acquiring an additional 5,341 shares during the period. OMERS ADMINISTRATION Corp purchased a new position in shares of Rapid Micro Biosystems in the 4th quarter valued at about $71,000. Barclays PLC acquired a new position in Rapid Micro Biosystems in the 4th quarter worth about $72,000. XTX Topco Ltd acquired a new position in Rapid Micro Biosystems in the 2nd quarter worth about $144,000. Finally, Goldman Sachs Group Inc. purchased a new position in Rapid Micro Biosystems during the fourth quarter worth approximately $160,000. Institutional investors and hedge funds own 52.60% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Wall Street Zen upgraded shares of Rapid Micro Biosystems from a “strong sell” rating to a “sell” rating in a research note on Sunday, May 31st. Lake Street Capital decreased their target price on shares of Rapid Micro Biosystems from $8.00 to $7.00 and set a “buy” rating for the company in a research report on Friday, May 22nd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Friday, July 17th. Finally, KeyCorp cut their price target on Rapid Micro Biosystems from $8.00 to $5.00 and set an “overweight” rating on the stock in a research report on Friday, May 29th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Rapid Micro Biosystems presently has a consensus rating of “Hold” and a consensus price target of $6.00.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.